I
I

Illumina

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Trustbusters pick fight that can make friends

BREAKINGVIEWS-Trustbusters pick fight that can make friends The author is a Reuters Breakingviews columnist. The opinions expressed are their own. CHICAGO, March 24 (Reuters Breakingviews) - After a year of fighting losing battles, one of the United States’ biggest trustbusters is taking on a fight where it will be easy to find support. The Federal Trade Commission proposed new rules on Thursday that would make canceling subscriptions less burdensome for consumers.
F
I
N

Carl Icahn Open Letter To Shareholders Of Illumina

BRIEF-Carl Icahn Open Letter To Shareholders Of Illumina March 24 (Reuters) - Carl Icahn: CARL ICAHN - RELEASED OPEN LETTER TO SHAREHOLDERS OF ILLUMINA CARL ICAHN - TO COMMENCE "IMMEDIATE INVESTIGATION" INTO DECISION BY ILLUMINA'S BOARD TO CLOSE GRAIL ACQUISITION Further company coverage: ILMN.O
I

Icahn claims Illumina directors asked for insurance for Grail deal approval

UPDATE 2-Icahn claims Illumina directors asked for insurance for Grail deal approval Adds Illumina response March 24 (Reuters) - Carl Icahn on Friday came down heavily on Illumina Inc ILMN.O , saying its directors demanded extra personal liability insurance against any potential claims related to the acquisition of Grail in 2021 before agreeing to signing off on the deal.
I

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Illumina, JetBlue March 24 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1600 ET on Friday: ** Carl Icahn on Friday came down heavily on Illumina Inc ILMN.O , saying its directors demanded extra personal liability insurance against any potential claims related to Grail's acquisition in 2021 before agreeing to signing off on the deal.
A
I
J
M
C

Icahn claims Illumina directors got insurance to close Grail deal -FT

Icahn claims Illumina directors got insurance to close Grail deal -FT March 24 (Reuters) - Carl Icahn has alleged that Illumina Inc's ILMN.O directors demanded extra personal liability insurance before they agreed to sign off on the life sciences company's $7.1 billion purchase of Grail in 2021, the Financial Times reported on Friday. The billionaire investor's claims , made in a letter to Illumina's shareholder that the FT saw, come as he continues his push for board seats on the world's larges
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.